Silencing of CD36 in human bladder cancer cells reduces the clonogenicity and the expression of stemness markers (ALDHA1, CD44, KLF4 and Nanog) induced by oxLDL exposure. This evidence concerns the gene CD36 and urinary bladder cancer.